FFAR4 improves the senescence of tubular epithelial cells by AMPK/SirT3 signaling in acute kidney injury

• Letian Yang
• Bo Wang
• Liang Ma

Article 30 November 2022

Featured

• 

  Antibody and T cell responses against wild-type and Omicron SARS-CoV-2 after third-dose BNT162b2 in adolescents

  • Xiaofeng Mu
  • Carolyn A. Cohen
  • Yu Lung Lau

  Article Open Access 14 Dec 2022
• 

  Analogous comparison unravels heightened antiviral defense and boosted viral infection upon immunosuppression in bat organoids

  • Xiaojuan Liu
  • Cun Li
  • Jie Zhou

  Article Open Access 19 Dec 2022
• 

  Aging and aging-related diseases: from molecular mechanisms to interventions and treatments

  • Jun Guo
  • Xiuqing Huang
  • Jian Li

  Review Article Open Access 16 Dec 2022
• 

  Identification of a class of potent USP25/28 inhibitors with broad-spectrum anti-cancer activity

  • Jin Peng
  • Kun Jiang
  • Pumin Zhang

  Letter Open Access 08 Dec 2022

• Published in partnership with West China Hospital, Sichuan University

  

Advertisement

Browse articles

• 

  The fungal mycobiome: a new hallmark of cancer revealed by pan-cancer analyses

  • Zhi Zong
  • Fangfang Zhou
  • Long Zhang

  Research Highlight Open Access 01 Feb 2023
• 

  Gonadotropin releasing hormone (GnRH): a hormone therapy boosts cognition in Down syndrome and dementia

  • Keenan Sterling
  • Ruixue Cao
  • Weihong Song

  Research Highlight Open Access 01 Feb 2023
• 

  Phase I study of camrelizumab in patients with advanced solid tumors

  • Yuxiang Ma
  • Jiaxin Cao
  • Li Zhang

  Letter Open Access 01 Feb 2023
• 

  GPR162 activates STING dependent DNA damage pathway as a novel tumor suppressor and radiation sensitizer

  • Yao Long
  • Jiaxing Guo
  • Yongguang Tao

  Article Open Access 01 Feb 2023
• 

  The cGAS-STING pathway: a therapeutic target in chromosomally unstable cancers

  • Haiyan Yan
  • Weiguo Lu
  • Fangwei Wang

  Research Highlight Open Access 30 Jan 2023
• 

  Intestinal dysbiosis exacerbates the pathogenesis of psoriasis-like phenotype through changes in fatty acid metabolism

  • Qixiang Zhao
  • Jiadong Yu
  • Jiong Li

  Article Open Access 30 Jan 2023
• 

  Meplazumab in hospitalized adults with severe COVID-19 (DEFLECT): a multicenter, seamless phase 2/3, randomized, third-party double-blind clinical trial

  • Huijie Bian
  • Liang Chen
  • Ping Zhu

  Article Open Access 30 Jan 2023
• 

  Single-cell RNA-sequencing reveals radiochemotherapy-induced innate immune activation and MHC-II upregulation in cervical cancer

  • Chao Liu
  • Xiaohui Li
  • Jinming Yu

  Article Open Access 30 Jan 2023
• 

  Role of the miR-301a/Fra-2/GLIPR1 axis in lung cancer cisplatin resistance

  • Gian Luca Rampioni Vinciguerra
  • Marina Capece
  • Carlo M. Croce

  Letter Open Access 27 Jan 2023

Trending - Altmetric

• 

  ACE2-independent infection of T lymphocytes by SARS-CoV-2

• 

  Strong attenuation of SARS-CoV-2 Omicron BA.1 and increased replication of the BA.5 subvariant in human cardiomyocytes

• 

  Azvudine is a thymus-homing anti-SARS-CoV-2 drug effective in treating COVID-19 patients

• 

  Fc effector of anti-Aβ antibody induces synapse loss and cognitive deficits in Alzheimer’s disease-like mouse model

• 

  This journal is a member of and subscribes to the principles of the Committee on Publication Ethics.

•